2022

Conferences and Events

Be sure to stop by and chat with the iRepertoire team.

We’ll be at our booth ready to chat with you about all things immune sequencing.

Come learn about our different service options for single cell V(D)J and bulk repertoire sequencing. Find out the latest developments happening at iRepertoire and discover how immune sequencing is empowering immunology research across the board from immuno-oncology to infectious disease.

img-team
img-calander-icon

Upcoming 2022 conferences and events

April

4-8

AACR Annual Meeting 2022

Booth #2425
Ernest N. Morial Convention Center,
New Orleans, LA

MAY

6-10

IMMUNOLOGY2022™ AAI Annual Meeting

Booth #345
Oregon Convention Center, Portland, OR

See poster

JUNE

6-8

24th TRCCC Annual Meeting

Seven Springs Mountain Resort, Champion, PA

NOV

8-12

Society for Immunotherapy of Cancer (SITC)

Boston Convention and Exhibition Center,
Boston, MA

Abstract ID: 2809

Development of a cell free virus free beads-based SARS-Cov-2 virus neutralization assay

Technological Innovations in Immunology

Sunday May 8, 2022, 2:30 pm-4:45 pm

Abstract ID: 2848

Analysis of human BCR-IgH from genomic DNA with UMI incorporation

Technological Innovations in Immunology II

Monday May 9, 2022, 2:30 pm-3:45 pm

Single cell sequencing for CAR-T cell therapy development & immunotherapy trials

A patient’s unique profile of B and T cells determines their ability to neutralize cancer cells and is predictive of their response to immunotherapies. But typical immune cell sequencing approaches do not preserve crucial information related to the cognate pairing of receptor chains and fail to capture critically important rare cell types.

With our single cell sequencing service, iPair™, you can specifically capture physically paired variable regions in individual T cells and B cells for improved sensitivity, characterization, and resolution. Go from cells to mapped and paired receptor data visualized through our proprietary iPair Analyzer software.

Single cell sequencing and transcriptome profiling can be used to screen cancer patient samples for specific cellular biomarkers, such as PD1 and CTLA-4, to identify patients likely to respond in clinical trials. Single cell analysis can also be used to assess CAR-T cell therapy development, track cellular clonality and evaluate immune cell activation following antigen stimulation. High-resolution profiling may provide clues into patterns of variable immune cell activity and immunotherapy response.

img-bulk-repertoire-sequencing

Bulk repertoire sequencing

Immune repertoire analysis for diagnosis, prognosis, and treatment monitoring

  • Clonal propagation and repertoire diversity correlate with diagnosis/prognosis
  • TCR and BCR expression patterns correlate with treatment efficacy
  • Novel immune sequencing tools enable tracking of all 7 chains for the entire length of immunotherapy studies

Ready to get started?

iPair/iPair + services

iRepertoire serves as a leader in the field of immune repertoire sequencing. We invite you to consult with our team of scientists to discover how iPair/iPair+ services can accelerate your analysis of immune cell function and diversity.

Schedule a consultation for single cell sequencing.